期刊文献+

Dimethyltryptamine(DMT):a biochemical Swiss Army knife in neuroinflammation and neuroprotection?

Dimethyltryptamine(DMT):a biochemical Swiss Army knife in neuroinflammation and neuroprotection?
下载PDF
导出
摘要 The inflammatory theory of many neuropsychiatric illnesses has become an emerging trend in modern medicine.Various immune mechanisms–mainly via the activity of microglia–may contribute to the etiology and symptomatology of diseases,such as schizophrenia,bipolar disorder,depression,or Alzheimer’s disease(Deleidi et al.,2015;Khandaker et al., The inflammatory theory of many neuropsychiatric illnesses has become an emerging trend in modern medicine.Various immune mechanisms–mainly via the activity of microglia–may contribute to the etiology and symptomatology of diseases,such as schizophrenia,bipolar disorder,depression,or Alzheimer’s disease(Deleidi et al.,2015;Khandaker et al.,
出处 《Neural Regeneration Research》 SCIE CAS CSCD 2016年第3期396-397,共2页 中国神经再生研究(英文版)
关键词 biochemical schizophrenia knife DMT bipolar microglia Swiss etiology inflammation neuronal biochemical schizophrenia knife DMT bipolar microglia Swiss etiology inflammation neuronal
  • 相关文献

参考文献19

  • 1Deleidi M, Jiggle M, Rubino G (2015) Immuneaging, dysmetabolism, and inflammation in neurological diseases. Front Neurosci 9:172.
  • 2Fontanilla D, Johannessen M, Hajipour AR, Cozzi NV, Jackson MB, Ruoho AE (2009) The hallucinogen N,N-dimethyltryptamine (DMT) is an en- dogenous sigma-1 receptor regulator. Science 323:934-937.
  • 3Frecska E, Szabo A, Winkelman MI, Luna LE, McKenna DI (2013) A possibly sigma-1 receptor mediated role of dimethyltryptamine in tissue protec- tion, regeneration, and immunity. J Neural Transm 120:1295-1303.
  • 4Hayashi T (2015) Conversion of psychological stress into cellular stress re- sponse: roles of the sigma-1 receptor in the process. Psychiatry Clin Neu- rosci 69:179-191.
  • 5Keiser MJ, Setola V, Irwin IJ, Laggner C, Abbas AI, Hufeisen SJ, Jensen NH, Kuijer MB, Matos RC, Tran TB, Whaley R, Glennon RA, Hert J, Thomas KL, Edwards DD, Shoichet BK, Roth BL (2009) Predicting new molecular targets for known drugs. Nature 462:175-181.
  • 6Khandaker GM, Cousins L, Deakin J, Lennox BR, Yolken R, Jones PB (2015) Inflammation and immunity in schizophrenia: implications for patho- physiology and treatment. Lancet Psychiatry 2:258-270.
  • 7Kothur K, Wienholt L, Brilot F, Dale RC (2016) CSF cytokines/chemokines as biomarkers in neuroinflammatory CNS disorders: A systematic review. Cytokine 77:227-237.
  • 8Pal A, Fontanilla D, Gopalakrishnan A, Chae YK, Markley IL, Ruoho AE (2012) The sigma- 1 receptor protects against cellular oxidative stress and activates antioxidant response elements. Eur J Pharmaco1682:12-20.
  • 9Penas C, Pascual-Font A, Mancuso R, Fords J, Casas C, Navarro X (2011) Sig- ma receptor agonist 2-(4-morpholinethgl)l phenylcyclohexanecarboxy/ate (Pre084) increases GDNF and BiP expression and promotes neuroprotec- tion after root avulsion injury. J Neurotrauma 28:831-840.
  • 10Ray TS (2010) Psychedelics and the human receptorome. PLoS One 5:e9019.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部